American Journal of Roentgenology, Vol 172, 1347-1351, Copyright © 1999 by American Roentgen Ray Society

ARTICLES

MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic- pathologic correlation

MG Harisinghani, S Saini, R Weissleder, PF Hahn, RK Yantiss, C Tempany, BJ Wood and PR Mueller
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

OBJECTIVE: The purpose of this study was to administer ultrasmall superparamagnetic iron oxide (USPIO) and compare changes in signal intensity of lymph nodes in patients with primary abdominal and pelvic malignancies. Also, we correlated radiographic with pathologic findings. SUBJECTS AND METHODS: Nineteen patients with proven primary abdominal or pelvic cancer (prostatic [n = 10]; colonic [n = 5]; endometrial [n = 1]; Merkel cell tumor [n = 1]; lymphoma [n = 1]; seminoma [n = 1]) were enrolled as part of our phase II and phase III clinical trials. In these patients, 49 lymph nodes (mean size, 1.4 cm) revealed on CT or MR imaging were evaluated on T1-weighted spin-echo, T2-weighted fast spin-echo, and T2*-weighted gradient-echo MR imaging at 1.5 T 24-36 hr after IV administration of USPIO. Quantitative analyses used measurements of unenhanced and enhanced region-of- interest values in lymph nodes. Qualitative assessment used subjective evaluation and classification of changes in signal intensity. All patients underwent lymph node biopsy or surgical dissection followed by histopathologic correlation. RESULTS: Of the 49 lymph nodes that were evaluated, 20 were benign and 29 were malignant. A decrease in nodal signal intensity on enhanced T2-weighted and T2*-weighted gradient-echo images was seen in 20 benign lymph nodes and two malignant lymph nodes. No appreciable signal change was noted in 27 of the 29 malignant lymph nodes. The mean signal intensity on fast spin-echo T2-weighted images for benign lymph nodes changed from 186.48 (unenhanced) to 73.66 (enhanced). Conversely, mean signal intensity for malignant lymph nodes was relatively unchanged from 191.17 (unenhanced) to 183.18 (enhanced). CONCLUSION: USPIO appears to be a useful MR contrast agent for characterizing benign and malignant lymph nodes based on the enhancement criteria evaluated in our study.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir Molecular Imaging Techniques in Body Imaging Radiology, November 1, 2007; 245(2): 333 - 356. [Abstract] [Full Text] [PDF]

				V S Khoo and D L Joon New developments in MRI for target volume delineation in radiotherapy Br. J. Radiol., September 1, 2006; 79(Special_Issue_1): S2 - S15. [Abstract] [Full Text] [PDF]

				W. M. L. L. G. Deserno, M. G. Harisinghani, M. Taupitz, G. J. Jager, J. A. Witjes, P. F. Mulders, C. A. Hulsbergen van de Kaa, D. Kaufmann, and J. O. Barentsz Urinary Bladder Cancer: Preoperative Nodal Staging with Ferumoxtran-10-enhanced MR Imaging Radiology, November 1, 2004; 233(2): 449 - 456. [Abstract] [Full Text] [PDF]

				M. S. Deloire, T. Touil, B. Brochet, V. Dousset, J.-M. Caille, and K. G Petry Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment Multiple Sclerosis, October 1, 2004; 10(5): 540 - 548. [Abstract] [PDF]

				M. Torabi, S. L. Aquino, and M. G. Harisinghani Current Concepts in Lymph Node Imaging J. Nucl. Med., September 1, 2004; 45(9): 1509 - 1518. [Abstract] [Full Text] [PDF]

				S. Bipat, A. S. Glas, F. J. M. Slors, A. H. Zwinderman, P. M. M. Bossuyt, and J. Stoker Rectal Cancer: Local Staging and Assessment of Lymph Node Involvement with Endoluminal US, CT, and MR Imaging--A Meta-Analysis Radiology, September 1, 2004; 232(3): 773 - 783. [Abstract] [Full Text] [PDF]

				M. G. Harisinghani, W. T. Dixon, M. A. Saksena, E. Brachtel, D. J. Blezek, P. J. Dhawale, M. Torabi, and P. F. Hahn MR Lymphangiography: Imaging Strategies to Optimize the Imaging of Lymph Nodes with Ferumoxtran-10 RadioGraphics, May 1, 2004; 24(3): 867 - 878. [Abstract] [Full Text] [PDF]

				Y. Anzai, C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, et al. Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10-enhanced MR Imaging: Phase III Safety and Efficacy Study Radiology, September 1, 2003; 228(3): 777 - 788. [Abstract] [Full Text] [PDF]

				J. A. Frank, B. R. Miller, A. S. Arbab, H. A. Zywicke, E. K. Jordan, B. K. Lewis, L. H. Bryant Jr, and J. W. M. Bulte Clinically Applicable Labeling of Mammalian and Stem Cells by Combining Superparamagnetic Iron Oxides and Transfection Agents Radiology, August 1, 2003; 228(2): 480 - 487. [Abstract] [Full Text] [PDF]

				E. S. Siegelman Invited Commentary RadioGraphics, July 1, 2003; 23(4): 981 - 981. [Full Text] [PDF]

				M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer N. Engl. J. Med., June 19, 2003; 348(25): 2491 - 2499. [Abstract] [Full Text] [PDF]

				V. Kundra and P. M. Silverman Imaging in the Diagnosis, Staging, and Follow-Up of Cancer of the Urinary Bladder Am. J. Roentgenol., April 1, 2003; 180(4): 1045 - 1054. [Full Text] [PDF]

				T H Saunders, H K Mendes Ribeiro, and F V Gleeson New techniques for imaging colorectal cancer: the use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up Br. Med. Bull., December 1, 2002; 64(1): 81 - 99. [Abstract] [Full Text] [PDF]

				A. H. Kaim, T. Wischer, T. O'Reilly, G. Jundt, J. Frohlich, G. K. von Schulthess, and P. R. Allegrini MR Imaging with Ultrasmall Superparamagnetic Iron Oxide Particles in Experimental Soft-Tissue Infections in Rats Radiology, December 1, 2002; 225(3): 808 - 814. [Abstract] [Full Text] [PDF]

				S. A. A. Sohaib, P. S. Richards, T. Ind, A. R. Jeyarajah, J. H. Shepherd, I. J. Jacobs, and R. H. Reznek MR Imaging of Carcinoma of the Vulva Am. J. Roentgenol., February 1, 2002; 178(2): 373 - 377. [Abstract] [Full Text] [PDF]

				J. R. Thornbury, D. K. Ornstein, P. L. Choyke, C. P. Langlotz, and J. C. Weinreb Prostate Cancer: What Is the Future Role for Imaging? Am. J. Roentgenol., January 1, 2001; 176(1): 17 - 22. [Full Text]